Ionis Pharmaceuticals
Ionis and Novartis partner for CVD treatment programme
August 4, 2023Business Services Cardiology, Ionis Pharmaceuticals, License Agreement, Novartis, cvd
Ionis Pharmaceuticals has announced that it has entered into a new collaboration and license agreement with Novartis, aiming to discover, …
Patient death sparks safety worries in Ionis trial
May 16, 2017Manufacturing and Production, Research and Development Ionis Pharmaceuticals
Ionis Pharmaceuticals announced the results from a Phase 3 trial of its drug to treat patients with familial amyloid polyneuropathy …
Novartis and Ionis enter $1bn cardiovascular drug deal
January 6, 2017Medical Communications, Research and Development, Sales and Marketing Akcea, Akcea Therapeutics, Ionis, Ionis Pharmaceuticals, cardiovascular
Ionis Pharmaceuticals and one of its wholly-owned subsidiaries Akcea Therapeutics have entered into a partnership with Novartis worth potentially more …
